Tessa Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Out of Business

Tessa Therapeutics General Information

Description

Developer of a biotechnology platform designed to focus on developing autologous and allogeneic cell therapies for the treatment of cancer. The company's platform redirects the body's potent anti-viral immune response to recognize and kill cancer cells, enabling healthcare providers to change the procedure of cancer treatment and give patients a new lease on life.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8 Temasek Boulevard
  • Number 24-02 Suntec Tower 3
  • Singapore, 038988
  • Singapore
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 8 Temasek Boulevard
  • Number 24-02 Suntec Tower 3
  • Singapore, 038988
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tessa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 30-Jun-2023 Completed Out of Business
4. Later Stage VC (Series A) 09-Jun-2022 Completed Clinical Trials - General
3. Accelerator/Incubator Completed Clinical Trials - General
2. Later Stage VC 01-Apr-2018 $50M $130M Completed Clinical Trials - General
1. Later Stage VC 21-Dec-2017 $80M $80M Completed Clinical Trials - General
To view Tessa Therapeutics’s complete valuation and funding history, request access »

Tessa Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to focus on developing autologous and allogeneic cell therapies for the t
Drug Discovery
Singapore, Singapore
200 As of 2023

Boston, MA
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tessa Therapeutics Competitors (41)

One of Tessa Therapeutics’s 41 competitors is IFM Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IFM Therapeutics Venture Capital-Backed Boston, MA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Kite Pharma Formerly VC-backed Santa Monica, CA
Oncorus Formerly VC-backed Andover, MA
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
You’re viewing 5 of 41 competitors. Get the full list »

Tessa Therapeutics Patents

Tessa Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024035342-A1 B7-h3 antigen-binding molecules Inactive 08-Aug-2022
WO-2024035341-A1 Cd30 antigen-binding molecules Inactive 08-Aug-2022
WO-2024035343-A1 Chimeric antigen receptor domains Inactive 08-Aug-2022
WO-2023198744-A1 Therapeutic t cell product Inactive 13-Apr-2022
WO-2023104910-A1 Treatment of lymphoma Inactive 08-Dec-2021 A61K39/39541
To view Tessa Therapeutics’s complete patent history, request access »

Tessa Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tessa Therapeutics Investments & Acquisitions (2)

Tessa Therapeutics’s most recent deal was a Joint Venture with Tessa Therapeutics & China-Singapore Guangzhou Knowledge City(Joint venture) for . The deal was made on 12-Jun-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tessa Therapeutics & China-Singapore Guangzhou Knowledge City(Joint venture) 12-Jun-2019 Joint Venture Drug Discovery
Euchloe Bio 23-Mar-2017 Merger/Acquisition Biotechnology
To view Tessa Therapeutics’s complete investments and acquisitions history, request access »

Tessa Therapeutics FAQs

  • When was Tessa Therapeutics founded?

    Tessa Therapeutics was founded in 2011.

  • Where is Tessa Therapeutics headquartered?

    Tessa Therapeutics is headquartered in Singapore, Singapore.

  • What is the size of Tessa Therapeutics?

    Tessa Therapeutics has 200 total employees.

  • What industry is Tessa Therapeutics in?

    Tessa Therapeutics’s primary industry is Drug Discovery.

  • Is Tessa Therapeutics a private or public company?

    Tessa Therapeutics is a Private company.

  • What is Tessa Therapeutics’s current revenue?

    The current revenue for Tessa Therapeutics is .

  • How much funding has Tessa Therapeutics raised over time?

    Tessa Therapeutics has raised $256M.

  • Who are Tessa Therapeutics’s competitors?

    IFM Therapeutics, Inovio Pharmaceuticals, Kite Pharma, Oncorus, and Aro Biotherapeutics are some of the 41 competitors of Tessa Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process